The activation of TGF-β signaling decreases the bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI), SMAD7, and increases the SMAD2/3/4 proteins, resulting in the excessive production of ECM and the progression of liver fibrosis [15, 17]. Here, SMAD2 is linked to Hepatic fibrosis.